Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 23;20(1):23.
doi: 10.1186/s13223-024-00890-y.

Circ_0070934 promotes MGAT3 expression and inhibits epithelial-mesenchymal transition in bronchial epithelial cells by sponging miR-199a-5p

Affiliations

Circ_0070934 promotes MGAT3 expression and inhibits epithelial-mesenchymal transition in bronchial epithelial cells by sponging miR-199a-5p

Ziqi Ding et al. Allergy Asthma Clin Immunol. .

Abstract

Background: Circular RNA (circRNA) has the potential to serve as a crucial regulator in the progression of bronchial asthma. The objective of this investigation was to elucidate the functional dynamics of the circ_0070934/miR-199a-5p/Mannoside acetylglucosaminyltransferase 3 (MGAT3) axis in the development of asthma.

Methods: Circ_0070934, miR-199a-5p and MGAT3 in peripheral venous blood of 38 asthmatic patients and 43 healthy controls were detected by qRT-PCR, and the expression of MGAT3 protein was examined by ELISA. The GSE148000 dataset was analyzed for differences in MGAT3. The BEAS-2B cells were transfected with circ_0070934 plasmid and small interfering RNA, miR-199a-5p mimics and inhibitors. The apoptosis level was detected by flow cytometry and MGAT3 was detected by qRT-PCR and Western blot. The expression of E-cadherin, N-cadherin, Vimentin was examined by Western blot. Interleukin-4 (IL-4) and IL-13 were used to co-stimulate BEAS-2B cells as an asthmatic airway epithelial cell model. BEAS-2B cells exposed to type 2 cytokines (IL-4 and IL-13) were treated with circ_0070934 plasmid, and the expression of E-cadherin, N-cadherin, and Vimentin was detected by Western blot. The binding relationships were verified using dual-luciferase reporter assay and miRNA pull-down assay.

Results: The expression of circ_0070934 and MGAT3 in peripheral venous blood of asthmatic patients was down-regulated, and the expression of miR-199a-5p was up-regulated. And the expression of MGAT3 was reduced in sputum of asthma patients. Down-regulating the expression of circ_0070934 could promote apoptosis of BEAS-2B cells and increase epithelial-mesenchymal transition (EMT), and this effect can be partially reversed by down-regulating miR-199a-5p. Circ_0070934 could inhibit the process of epithelial mesenchymal transition induced by IL-4 and IL-13 in BEAS-2B cells. In addition, miR-199a-5p could respectively bind to circ_0070934 and MGAT3.

Conclusion: The findings of this study indicate that circ_0070934 may function as a competitive endogenous RNA (ceRNA) of miR-199a-5p, thereby modulating the expression of MGAT3 and impacting the process of EMT in bronchial epithelial cells. These results contribute to the establishment of a theoretical framework for advancing the prevention and treatment strategies for asthma.

Keywords: Asthma; Epithelial-mesenchymal transition; Mannoside acetylglucosaminyltransferase 3; circ_0070934; miR-199a-5p.

PubMed Disclaimer

Conflict of interest statement

The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflicts with the subject matter or materials discussed in the manuscript apart from those disclosed.

Figures

Fig. 1
Fig. 1
circ_0070934, miR-199a-5p and MGAT3 were differentially expressed in asthma patients and healthy controls. A–C The expression of circ_0070934, miR-199a-5p and MGAT3 in peripheral venous blood of healthy controls (N = 43) and asthmatic patients (N = 38) was determined by qRT-PCR. D ELISA was used to detect the expression level of MGAT3 protein in peripheral plasma of healthy controls (N = 43) and asthmatic patients (N = 38). E The expression level of MGAT3 in sputum of healthy controls (N = 7) and asthmatic patients (N = 9) was presented by analyzing the GSE148000 gene expression profiling dataset. The data were presented as mean ± SEM. qRT-PCR and ELISA assays were repeated three times. ns, no significant, P > 0.05; *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001
Fig. 2
Fig. 2
Regulation of the expression of circ_0070934 and miR-199a-5p could affect the expression of MGAT3. A qRT-PCR was used to detect the expression of circ_0070934 after transfection of vector or circ_0070934 plasmid, and si-NC or si-circ_0070934 in BEAS-2B cells. B The expressions of miR-199a-5p in BEAS-2B cells after overexpression and knockdown miR-199a-5p was measured by qRT-PCR. C and D mRNA levels of MGAT3 in BEAS-2B cells after regulating circ_0070934 and miR-199a-5p was detected by qRT-PCR. E and F The expression level of MGAT3 protein in BEAS-2B cells was determined by Western blot. The data were presented as mean ± SEM. Our experiments were repeated three times. ns, no significant; P > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001
Fig. 3
Fig. 3
Down-regulation of circ_0070934 can promote apoptosis and affect the process of EMT in BEAS-2B cells. A BEAS-2B cells were divided into four groups: si-NC, si-circ_0070934, inhibitor NC and miR-199a-5p inhibitor. The level of cell apoptosis after transfection was quantified by Flow cytometry. B and C Western blot was used to detect the expression levels of epithelial-mesenchymal transition related molecular markers, including E-cadherin, N-cadherin and vimentin after transfection of si-NC or si-circ_0070934, and vector or circ_0070934 plasmid in BEAS-2B cells. The data were presented as mean ± SEM. Our experiments were repeated three times. ns, no significant; P > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001
Fig. 4
Fig. 4
MiR-199a-5p could reverse the effect of circ_0070934 on apoptosis and EMT of BEAS-2B cells. A BEAS-2B cells were divided into four groups: si-NC + inhibitor NC, si-circ_0070934 + inhibitor NC, si-circ_0070934 + miR-199a-5p inhibitor, si-NC + miR-199a-5p inhibitor. Flow cytometry was used to measure the level of cell apoptosis. B BEAS-2B cells were divided into three groups: si-NC + inhibitor NC, si-circ_0070934 + inhibitor NC, and si-circ_0070934 + miR-199a-5p inhibitor. The expression levels of proteins associated with EMT was detected by Western blot. C BEAS-2B cells were divided into three groups: vector + miR-NC, circ_0070934 + miR-NC, and circ_0070934 + miR-199a-5p mimics. Western blot was used to determine the expression levels of proteins associated with EMT. The data were presented as mean ± SEM. Our experiments were repeated three times. ns, no significant; P > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001
Fig. 5
Fig. 5
Circ_0070934 suppressed the EMT process induced by BEAS-2B cells exposed to IL-4 and IL-13. BEAS-2B cells were divided into three groups: vector, vector + IL4/13, and circ_0070934 + IL-4/13. Western blot was used to detect expression levels of proteins associated with EMT in BEAS-2B cells. The data were presented as mean ± SEM. Our experiments were repeated three times. ns, no significant; P > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001
Fig. 6
Fig. 6
Circ_0070934 had a targeted binding relationship with miR-199a-5p. A There are potential base binding sites between circ_0070934 and miR-199a-5p. B Dual-luciferase reporter assay was conducted to explicit the binding relationship between circ_0070934 and miR-199a-5p. C MiR-199a-5p-pull-down and NC-pull-down were the two groups of cells transfected with miR-199a-5p and NC probes, respectively. The input was the sample control, equivalent to total RNA, and the pulldown was the RNA after magnetic bead pull-down. There are four groups of RNA. The expression of hsa circ 0070934 and GAPDH were detected by qPCR. The data were presented as mean ± SEM. Our experiments were repeated three times. ns, no significant; P > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001
Fig. 7
Fig. 7
MGAT3 was a downstream target of miR-199a-5p. A There are potential base binding sites between MGAT3 and miR-199a-5p. B Dual-luciferase reporter assay was used to verify the binding relationship between MGAT3 and miR-199a-5p. C BEAS-2B cells were divided into four groups: vector, circ_0070934, si-NC and si-circ_0070934. D BEAS-2B cells were divided into four groups: miR-NC, miR-199a-5p mimics, inhibitor NC and miR-199a-5p inhibitor. C and D mRNA expression level of MGAT3 was determined by qRT-PCR. E and F The protein expression level of MGAT3 was determined by Western blot. The data were presented as mean ± SEM. Our experiments were repeated three times. ns, no significant; P > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001
Fig.8
Fig.8
Schematic diagram demonstrating mechanisms by which circ_0070934 promotes MGAT3 expression and inhibits EMT progress in bronchial epithelial cells by sponging miR-199a-5p

Similar articles

Cited by

References

    1. Padem N, Saltoun C. Classification of asthma. Allergy Asthma Proc. 2019;40:385–388. doi: 10.2500/aap.2019.40.4253. - DOI - PubMed
    1. Johnson JR, Roos A, Berg T, Nord M, Fuxe J. Chronic respiratory aeroallergen exposure in mice induces epithelial-mesenchymal transition in the large airways. PLoS ONE. 2011;6:e16175. doi: 10.1371/journal.pone.0016175. - DOI - PMC - PubMed
    1. Gour N, Wills-Karp M. IL-4 and IL-13 signaling in allergic airway disease. Cytokine. 2015;75:68–78. doi: 10.1016/j.cyto.2015.05.014. - DOI - PMC - PubMed
    1. Allen JE. IL-4 and IL-13: regulators and effectors of wound repair. Annu Rev Immunol. 2023;41:229–254. doi: 10.1146/annurev-immunol-101921-041206. - DOI - PubMed
    1. Moonwiriyakit A, Yimnual C, Noitem R, Dinsuwannakol S, Sontikun J, Kaewin S, et al. GPR120/FFAR4 stimulation attenuates airway remodeling and suppresses IL-4 and IL-13-induced airway epithelial injury via inhibition of STAT6 and Akt. Biomed Pharmacother. 2023;168:115774. doi: 10.1016/j.biopha.2023.115774. - DOI - PubMed